| DEALFLOWUPDATE Issue #11. Friday, June 22 |
What do you know about venture capital? In this issue I want to take a moment to reflect and share some of our observations from building Zoic. Since starting Zoic five years ago and the thousands of deals since then, we have come away with what we believe are a handful of interesting observations. First, while having a high quantity of deal flow is important, ensuring that they are high quality is just as important. To that end, cultivating a broad network of personal relationships with everyone from academic labs to incubators is key. Second, many early stage investors spend a surprisingly limited amount of time on diligence. While time consuming, an intensive diligence process along with stringent deal criteria is critical to uncovering red flags and insights that would otherwise remain hidden. Finally, active investors whom have a broad based network, either of partners or advisors, appear to be positioned to create significantly more value. Accomplished largely through addressing problems before they arise. What observations do you have about venture capital or early stage investing? Here at Zoic we believe that it is critical to constantly be learning not only from our experiences but from our partners as well. As such, what observations or insights can you share? Thanks for reading and I hope everyone has an enjoyable weekend… -Neal P.S. Our readership has grown tremendously over the past 11 issues, if you have found value here, please subscribe and continue to share with others. Connect with us, we would love to hear from you! Spotlight  Podcast The Future of Healthcare Guests John Milne and Steve Stack discuss the future of healthcare and the innovations, policy changes as well as roadblocks they see contributing to a new healthcare landscape. John Milne, MD, MBA, FACEP, is Senior Vice President, Real Estate and Construction at Providence St. Joseph Health. Steve Stack, MD, MBA is an emergency physician and healthcare advocate and formerly served as the president of the American Medical Association. Listen Now On iTunes or RSS Episode ArchiveShareTweetForward |
Dealflow Broncus Medical Closes $15M Series A Funding Diagnostic methods such as spectroscopy are not only extremely promising for finding disease, but also in guiding the treatments. We’ve mentioned this previously when talking about companion diagnositcs, in the context of molecular diagnostic methods. This is also true about spectroscopic methods, especially for cancer and other surgeries. Companies, especially in the robotic space are interested in adding real-time diagnostic capability to their devices to improve and even semi-automate operations. Read More  Brain-interface Tech Startup Paradromics Raises $7m In Seed Funding We have recently received, and are evaluating a number of very interesting brain interfacing technologies. Advancements in integrated circuits, biocompatible materials and machine learning now make possible both implantable and noninvasive devices to monitor and treat the brain. Read More  Robotics pioneer clinches record $100m funding as Chinese invest In addition to adding functionality to existing robotic devices, robotic surgery itself is a strong interest field. There are an increasing number of companies and potential deals that we see; however, what we are truly looking for are surgical robotics that can create new use scenarios, rather than just improving on existing surgeries. Read More  Fertility-Tracking Bracelet Raises $30M, Focusing On Women’s Health We have also seen a rise in devices and diagnostics centering on women’s health. For example, fertility tracking. Molecular diagnostics are also seen in advancing and improving on prenatal health, as discussed previously. Read More  Cerebral Therapeutics Closes $3M Series A Financing Epilepsy is a major issue affecting 3 million people in the US every year. However, there is still a lack of adequate solutions. Pharmaceuticals can either lack efficacy or have severe side effects. There is surgery available, but there is a lack of accurate knowledge about where to perform the operation. Improvements are emerging, either on the pharma side or on surgical solutions. Read More What We’re Reading KV Revisiting: Vinod Kholsa’s Speculations and Musings of a Technology Optimist KPCB Baby Boomers: How digital health tools can save you money and your life EY Megatrends will impact cities and healthcare WSJ Dr. Atul Gawande to lead Amazon, JPMorgan, Berkshire healthcare venture Connect With Zoic Capital |
| The Biweekly Dealflow Update, curated by the team at Zoic Capital. |
Recommended For You
Neuralink and the Long Path to Approval
Neuralink and the Long Path to Approval
zoicaccountSeptember 11, 2021
As 2021 begins, we reflect on scientific advancements in 2020 spurred by the COVID-19 crisis
As 2021 begins, we reflect on scientific advancements in 2020 spurred by the COVID-19 crisis
zoicaccountJanuary 31, 2021
COVID-19, Alzheimer’s, and Cancer Testing
COVID-19, Alzheimer’s, and Cancer Testing
zoicaccountDecember 7, 2020